19-43508784-C-T
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM2PM5PP3_ModeratePP5_Very_Strong
The NM_014297.5(ETHE1):c.586G>A(p.Asp196Asn) variant causes a missense change. The variant allele was found at a frequency of 0.00000896 in 1,450,728 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D196V) has been classified as Likely pathogenic.
Frequency
Consequence
NM_014297.5 missense
Scores
Clinical Significance
Conservation
Publications
- ethylmalonic encephalopathyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ETHE1 | NM_014297.5 | c.586G>A | p.Asp196Asn | missense_variant | Exon 5 of 7 | ENST00000292147.7 | NP_055112.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ETHE1 | ENST00000292147.7 | c.586G>A | p.Asp196Asn | missense_variant | Exon 5 of 7 | 1 | NM_014297.5 | ENSP00000292147.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000255 AC: 6AN: 235178 AF XY: 0.0000158 show subpopulations
GnomAD4 exome AF: 0.00000896 AC: 13AN: 1450728Hom.: 0 Cov.: 31 AF XY: 0.0000111 AC XY: 8AN XY: 720464 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Ethylmalonic encephalopathy Pathogenic:5Other:1
This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PM2,PP2,PP3. -
- -
- -
- -
- -
This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 196 of the ETHE1 protein (p.Asp196Asn). This variant is present in population databases (rs763799125, gnomAD 0.006%). This missense change has been observed in individuals with ethylmalonic encephalopathy (PMID: 18593870, 36891747). ClinVar contains an entry for this variant (Variation ID: 488508). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt ETHE1 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects ETHE1 function (PMID: 23144459). This variant disrupts the p.Asp196 amino acid residue in ETHE1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 32362910). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
not provided Pathogenic:2
Published functional studies suggest a damaging effect resulting from a higher affinity of the enzyme for its substrate (PMID: 23144459); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 18593870, Sloan-Heggen2023[Abstract], 36891747, 23144459) -
ETHE1: PM2, PM3, PM5, PS3:Supporting -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at